Global Retrovirus-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Retrovirus-based gene therapy drugs are drugs that use retroviruses as vectors to introduce normal or modified genes into patient cells to treat genetic diseases, cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load therapeutic genes into retroviral vectors, allowing them to enter the patient's cells and express the required proteins to achieve therapeutic purposes.
The global Retrovirus-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Retrovirus-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world Retrovirus-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Retrovirus-Based Gene Therapy Drugs sales for 2023 through 2029. With Retrovirus-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retrovirus-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Retrovirus-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retrovirus-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retrovirus-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retrovirus-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retrovirus-Based Gene Therapy Drugs.
United States market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Retrovirus-Based Gene Therapy Drugs players cover GSK, Chaselection, MolMed, GILD, Denovo Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Retrovirus-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Retrovirus-based gene therapy drugs are drugs that use retroviruses as vectors to introduce normal or modified genes into patient cells to treat genetic diseases, cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load therapeutic genes into retroviral vectors, allowing them to enter the patient's cells and express the required proteins to achieve therapeutic purposes.
The global Retrovirus-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Retrovirus-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world Retrovirus-Based Gene Therapy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Retrovirus-Based Gene Therapy Drugs sales for 2023 through 2029. With Retrovirus-Based Gene Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retrovirus-Based Gene Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global Retrovirus-Based Gene Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retrovirus-Based Gene Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retrovirus-Based Gene Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retrovirus-Based Gene Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retrovirus-Based Gene Therapy Drugs.
United States market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Retrovirus-Based Gene Therapy Drugs players cover GSK, Chaselection, MolMed, GILD, Denovo Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Retrovirus-Based Gene Therapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CAR-T Therapy
- Autologous CD34+ Cell Gene Therapy
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CAR-T Therapy
- Autologous CD34+ Cell Gene Therapy
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Chaselection
- MolMed
- GILD
- Denovo Biopharma
- Pfizer
- Epeius
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Retrovirus-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Retrovirus-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Retrovirus-Based Gene Therapy Drugs Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Autologous CD34+ Cell Gene Therapy
2.3 Retrovirus-Based Gene Therapy Drugs Market Size by Type
2.3.1 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Retrovirus-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Retrovirus-Based Gene Therapy Drugs Market Size by Application
2.5.1 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 RETROVIRUS-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global Retrovirus-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Retrovirus-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RETROVIRUS-BASED GENE THERAPY DRUGS BY REGION
4.1 Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Retrovirus-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Retrovirus-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RETROVIRUS-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Retrovirus-Based Gene Therapy Drugs Forecast
10.1.3 APAC Retrovirus-Based Gene Therapy Drugs Forecast
10.1.4 Europe Retrovirus-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Forecast
10.2 Americas Retrovirus-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3 APAC Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Retrovirus-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.5 India Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4 Europe Retrovirus-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.2 France Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.3 UK Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market Retrovirus-Based Gene Therapy Drugs Forecast
10.6 Global Retrovirus-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Retrovirus-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Retrovirus-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Retrovirus-Based Gene Therapy Drugs Product Offered
11.1.3 GSK Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Chaselection
11.2.1 Chaselection Company Information
11.2.2 Chaselection Retrovirus-Based Gene Therapy Drugs Product Offered
11.2.3 Chaselection Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Chaselection Main Business Overview
11.2.5 Chaselection Latest Developments
11.3 MolMed
11.3.1 MolMed Company Information
11.3.2 MolMed Retrovirus-Based Gene Therapy Drugs Product Offered
11.3.3 MolMed Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 MolMed Main Business Overview
11.3.5 MolMed Latest Developments
11.4 GILD
11.4.1 GILD Company Information
11.4.2 GILD Retrovirus-Based Gene Therapy Drugs Product Offered
11.4.3 GILD Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GILD Main Business Overview
11.4.5 GILD Latest Developments
11.5 Denovo Biopharma
11.5.1 Denovo Biopharma Company Information
11.5.2 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product Offered
11.5.3 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Denovo Biopharma Main Business Overview
11.5.5 Denovo Biopharma Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Retrovirus-Based Gene Therapy Drugs Product Offered
11.6.3 Pfizer Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Epeius
11.7.1 Epeius Company Information
11.7.2 Epeius Retrovirus-Based Gene Therapy Drugs Product Offered
11.7.3 Epeius Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Epeius Main Business Overview
11.7.5 Epeius Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Retrovirus-Based Gene Therapy Drugs Market Size 2019-2030
2.1.2 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Retrovirus-Based Gene Therapy Drugs by Country/Region, 2019, 2023 & 2030
2.2 Retrovirus-Based Gene Therapy Drugs Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Autologous CD34+ Cell Gene Therapy
2.3 Retrovirus-Based Gene Therapy Drugs Market Size by Type
2.3.1 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Retrovirus-Based Gene Therapy Drugs Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Retrovirus-Based Gene Therapy Drugs Market Size by Application
2.5.1 Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
3 RETROVIRUS-BASED GENE THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Player
3.1.1 Global Retrovirus-Based Gene Therapy Drugs Revenue by Player (2019-2024)
3.1.2 Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Retrovirus-Based Gene Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RETROVIRUS-BASED GENE THERAPY DRUGS BY REGION
4.1 Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024)
4.2 Global Retrovirus-Based Gene Therapy Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.4 APAC Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.5 Europe Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.2 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Retrovirus-Based Gene Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RETROVIRUS-BASED GENE THERAPY DRUGS MARKET FORECAST
10.1 Global Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.1 Global Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.1.2 Americas Retrovirus-Based Gene Therapy Drugs Forecast
10.1.3 APAC Retrovirus-Based Gene Therapy Drugs Forecast
10.1.4 Europe Retrovirus-Based Gene Therapy Drugs Forecast
10.1.5 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Forecast
10.2 Americas Retrovirus-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.2 Canada Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.3 Mexico Market Retrovirus-Based Gene Therapy Drugs Forecast
10.2.4 Brazil Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3 APAC Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Retrovirus-Based Gene Therapy Drugs Market Forecast
10.3.2 Japan Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.3 Korea Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.4 Southeast Asia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.5 India Market Retrovirus-Based Gene Therapy Drugs Forecast
10.3.6 Australia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4 Europe Retrovirus-Based Gene Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.2 France Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.3 UK Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.4 Italy Market Retrovirus-Based Gene Therapy Drugs Forecast
10.4.5 Russia Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.2 South Africa Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.3 Israel Market Retrovirus-Based Gene Therapy Drugs Forecast
10.5.4 Turkey Market Retrovirus-Based Gene Therapy Drugs Forecast
10.6 Global Retrovirus-Based Gene Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Retrovirus-Based Gene Therapy Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Retrovirus-Based Gene Therapy Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Retrovirus-Based Gene Therapy Drugs Product Offered
11.1.3 GSK Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Chaselection
11.2.1 Chaselection Company Information
11.2.2 Chaselection Retrovirus-Based Gene Therapy Drugs Product Offered
11.2.3 Chaselection Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Chaselection Main Business Overview
11.2.5 Chaselection Latest Developments
11.3 MolMed
11.3.1 MolMed Company Information
11.3.2 MolMed Retrovirus-Based Gene Therapy Drugs Product Offered
11.3.3 MolMed Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 MolMed Main Business Overview
11.3.5 MolMed Latest Developments
11.4 GILD
11.4.1 GILD Company Information
11.4.2 GILD Retrovirus-Based Gene Therapy Drugs Product Offered
11.4.3 GILD Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GILD Main Business Overview
11.4.5 GILD Latest Developments
11.5 Denovo Biopharma
11.5.1 Denovo Biopharma Company Information
11.5.2 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product Offered
11.5.3 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Denovo Biopharma Main Business Overview
11.5.5 Denovo Biopharma Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Retrovirus-Based Gene Therapy Drugs Product Offered
11.6.3 Pfizer Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Epeius
11.7.1 Epeius Company Information
11.7.2 Epeius Retrovirus-Based Gene Therapy Drugs Product Offered
11.7.3 Epeius Retrovirus-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Epeius Main Business Overview
11.7.5 Epeius Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Retrovirus-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Autologous CD34+ Cell Gene Therapy
Table 5. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 8. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Retrovirus-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 13. Retrovirus-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 14. Retrovirus-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 19. Global Retrovirus-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 33. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Retrovirus-Based Gene Therapy Drugs
Table 39. Key Market Challenges & Risks of Retrovirus-Based Gene Therapy Drugs
Table 40. Key Industry Trends of Retrovirus-Based Gene Therapy Drugs
Table 41. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. GSK Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 46. GSK Retrovirus-Based Gene Therapy Drugs Product Offered
Table 47. GSK Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. GSK Main Business
Table 49. GSK Latest Developments
Table 50. Chaselection Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 51. Chaselection Retrovirus-Based Gene Therapy Drugs Product Offered
Table 52. Chaselection Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Chaselection Main Business
Table 54. Chaselection Latest Developments
Table 55. MolMed Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 56. MolMed Retrovirus-Based Gene Therapy Drugs Product Offered
Table 57. MolMed Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. MolMed Main Business
Table 59. MolMed Latest Developments
Table 60. GILD Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 61. GILD Retrovirus-Based Gene Therapy Drugs Product Offered
Table 62. GILD Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GILD Main Business
Table 64. GILD Latest Developments
Table 65. Denovo Biopharma Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 66. Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product Offered
Table 67. Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Denovo Biopharma Main Business
Table 69. Denovo Biopharma Latest Developments
Table 70. Pfizer Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 71. Pfizer Retrovirus-Based Gene Therapy Drugs Product Offered
Table 72. Pfizer Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Epeius Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 76. Epeius Retrovirus-Based Gene Therapy Drugs Product Offered
Table 77. Epeius Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Epeius Main Business
Table 79. Epeius Latest Developments
Table 1. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Retrovirus-Based Gene Therapy Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Autologous CD34+ Cell Gene Therapy
Table 5. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 8. Retrovirus-Based Gene Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Retrovirus-Based Gene Therapy Drugs Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 13. Retrovirus-Based Gene Therapy Drugs Key Players Head office and Products Offered
Table 14. Retrovirus-Based Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 19. Global Retrovirus-Based Gene Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 33. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Retrovirus-Based Gene Therapy Drugs
Table 39. Key Market Challenges & Risks of Retrovirus-Based Gene Therapy Drugs
Table 40. Key Industry Trends of Retrovirus-Based Gene Therapy Drugs
Table 41. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Retrovirus-Based Gene Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. GSK Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 46. GSK Retrovirus-Based Gene Therapy Drugs Product Offered
Table 47. GSK Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. GSK Main Business
Table 49. GSK Latest Developments
Table 50. Chaselection Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 51. Chaselection Retrovirus-Based Gene Therapy Drugs Product Offered
Table 52. Chaselection Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Chaselection Main Business
Table 54. Chaselection Latest Developments
Table 55. MolMed Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 56. MolMed Retrovirus-Based Gene Therapy Drugs Product Offered
Table 57. MolMed Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. MolMed Main Business
Table 59. MolMed Latest Developments
Table 60. GILD Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 61. GILD Retrovirus-Based Gene Therapy Drugs Product Offered
Table 62. GILD Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GILD Main Business
Table 64. GILD Latest Developments
Table 65. Denovo Biopharma Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 66. Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product Offered
Table 67. Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Denovo Biopharma Main Business
Table 69. Denovo Biopharma Latest Developments
Table 70. Pfizer Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 71. Pfizer Retrovirus-Based Gene Therapy Drugs Product Offered
Table 72. Pfizer Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Epeius Details, Company Type, Retrovirus-Based Gene Therapy Drugs Area Served and Its Competitors
Table 76. Epeius Retrovirus-Based Gene Therapy Drugs Product Offered
Table 77. Epeius Retrovirus-Based Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Epeius Main Business
Table 79. Epeius Latest Developments
LIST OF FIGURES
Figure 1. Retrovirus-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Retrovirus-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Retrovirus-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Retrovirus-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Retrovirus-Based Gene Therapy Drugs in Hospital
Figure 11. Global Retrovirus-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Retrovirus-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global Retrovirus-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. Retrovirus-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global Retrovirus-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. Retrovirus-Based Gene Therapy Drugs in Others
Figure 17. Global Retrovirus-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas Retrovirus-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Retrovirus-Based Gene Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Retrovirus-Based Gene Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Retrovirus-Based Gene Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Retrovirus-Based Gene Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Retrovirus-Based Gene Therapy Drugs in Hospital
Figure 11. Global Retrovirus-Based Gene Therapy Drugs Market: Hospital (2019-2024) & ($ millions)
Figure 12. Retrovirus-Based Gene Therapy Drugs in Diagnostic and Testing Laboratories
Figure 13. Global Retrovirus-Based Gene Therapy Drugs Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. Retrovirus-Based Gene Therapy Drugs in Academic and Research Organizations
Figure 15. Global Retrovirus-Based Gene Therapy Drugs Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. Retrovirus-Based Gene Therapy Drugs in Others
Figure 17. Global Retrovirus-Based Gene Therapy Drugs Market: Others (2019-2024) & ($ millions)
Figure 18. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
Figure 19. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Player in 2023
Figure 20. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 21. Americas Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 22. APAC Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 23. Europe Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size 2019-2024 ($ millions)
Figure 25. Americas Retrovirus-Based Gene Therapy Drugs Value Market Share by Country in 2023
Figure 26. United States Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 32. APAC Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 33. China Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. India Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. France Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Retrovirus-Based Gene Therapy Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 56. APAC Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 57. Europe Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 59. United States Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 60. Canada Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 61. Mexico Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 62. Brazil Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 63. China Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 64. Japan Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 65. Korea Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 67. India Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 68. Australia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 69. Germany Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 70. France Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 71. UK Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 72. Italy Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 73. Russia Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 74. Egypt Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 75. South Africa Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 76. Israel Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 77. Turkey Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Retrovirus-Based Gene Therapy Drugs Market Size 2025-2030 ($ millions)
Figure 79. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Retrovirus-Based Gene Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
